• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Tempus AI Inc.

    11/12/24 4:30:28 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology
    Get the next $TEM alert in real time by email
    SC 13G 1 formsc13g.htm

     

     

     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

    Schedule 13G

     

    (Rule 13d-102)

     

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    (Amendment No. )*

     

    Tempus AI, Inc.

    (Name of Issuer)

     

    Class A Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

     

    71535D106

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☒ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 71535D106 Schedule 13G Page 1 of 6

     

    1

    Names of Reporting Persons

     

    Red Sky Ventures LLC

     
    2

    Check the Appropriate Box if a Member of a Group

    (a) ☐

    (b) ☐

     

    3

    SEC Use Only

     

     

     
    4

    Citizenship or Place of Organization

     

    Delaware

     

    Number of Shares
    Beneficially Owned by
    Each Reporting Person
    With
    5

    Sole Voting Power

     

    0

    6

    Shared Voting Power

     

    16,560,249

    7

    Sole Dispositive Power

     

    0

    8

    Shared Dispositive Power

     

    16,560,249

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    16,560,249

    10

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

    Not Applicable

    11

    Percent of Class Represented by Amount in Row 9

     

    10.9%

    12

    Type of Reporting Person

     

    OO (Limited Liability Company)

     

     

     

     

    CUSIP No. 71535D106 Schedule 13G Page 2 of 6

     

    1

    Names of Reporting Persons

     

    Kimberly Jo Keywell

     
    2

    Check the Appropriate Box if a Member of a Group

    (a) ☐

    (b) ☐

     

    3

    SEC Use Only

     

     

     
    4

    Citizenship or Place of Organization

     

    United States

     

    Number of Shares
    Beneficially Owned by
    Each Reporting Person
    With
    5

    Sole Voting Power

     

    0

    6

    Shared Voting Power

     

    16,560,249

    7

    Sole Dispositive Power

     

    0

    8

    Shared Dispositive Power

     

    16,560,249

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    16,560,249

    10

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

    Not Applicable

    11

    Percent of Class Represented by Amount in Row 9

     

    10.9%

    12

    Type of Reporting Person

     

    IN

     

     

     

     

    CUSIP No. 71535D106 Schedule 13G Page 3 of 6

     

    ITEM 1. (a)Name of Issuer:

     

    Tempus AI, Inc. (the “Issuer”).

     

    (b)Address of Issuer’s Principal Executive Offices:

     

    600 West Chicago Avenue, Suite 510, Chicago, IL 60654

     

    ITEM 2. (a)Name of Person Filing:

     

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

     

    Red Sky Ventures LLC (“Red Sky”)

    Kimberly Jo Keywell

     

    (b)Address or Principal Business Office:

     

    The principal business address of each of the Reporting Persons is 1001 Green Bay Road, Suite 146, Winnetka, IL 60093.

     

    (c)Citizenship of each Reporting Person is:

     

    Red Sky is organized under the laws of the state of Delaware. Ms. Keywell is a citizen of the United States.

     

    (d)Title of Class of Securities:

     

    Class A common stock, par value $0.0001 per share (“Class A Common Stock”).

     

    (e)CUSIP Number:

     

    71535D106

     

    ITEM 3.  

     

    Not applicable.

     

     

     

     

    CUSIP No. 71535D106 Schedule 13G Page 4 of 6

     

    ITEM 4.Ownership.

     

    (a-c)

     

    The ownership information presented below represents beneficial ownership of shares of Class A Common Stock as of the date hereof, based upon 152,401,894 shares of Class A Common Stock outstanding as of November 4, 2024, as disclosed in the Issuer’s quarterly report on Form 10-Q, filed with the Securities and Exchange Commission on November 4, 2024.

     

    Reporting Person 

    Amount

    beneficially

    owned

      

    Percent

    of class:

       Sole
    power to
    vote or to
    direct
    the vote:
       Shared
    power to
    vote or to
    direct the
    vote:
      

    Sole power to dispose or to direct the disposition

    of:

      

    Shared

    power to

    dispose or

    to direct

    the

    disposition

    of:

     
    Red Sky Ventures LLC   16,560,249    10.9%   0    16,560,249         0    16,560,249 
    Kimberly Jo Keywell   16,560,249    10.9%   0    16,560,249    0    16,560,249 

     

    Red Sky is the record holder of the shares of Class A Commoon Stock reported herein. Ms. Keywell is the sole member and manager of Red Sky. As a result, Ms. Keywell may be deemed to share beneficial ownership of the shares of Class A Common Stock directly held by Red Sky.

     

    ITEM 5.Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    ITEM 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    ITEM 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    ITEM 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    ITEM 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    ITEM 10.Certification.

     

    Not applicable.

     

     

     

     

    CUSIP No. 71535D106 Schedule 13G Page 5 of 6

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: November 12, 2024    
           
        Red Sky Ventures LLC
           
        By: /s/ Kimberly Jo Keywell
        Name: Kimberly Jo Keywell
        Title: President
           
        Kimberly Jo Keywell
         
        /s/ Kimberly Jo Keywell

     

     

     

     

    CUSIP No. 71535D106 Schedule 13G Page 6 of 6

     

    LIST OF EXHIBITS

     

    Exhibit No. Description
       
    99 Joint Filing Agreement.

     

     

     

    Get the next $TEM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TEM

    DatePrice TargetRatingAnalyst
    4/21/2025$60.00Buy
    BTIG Research
    2/25/2025$50.00 → $55.00Overweight → Neutral
    Analyst
    2/12/2025Outperform → Mkt Perform
    William Blair
    2/5/2025$58.00 → $74.00Buy
    TD Cowen
    12/13/2024$60.00Outperform
    Wolfe Research
    12/9/2024$74.00Buy
    Guggenheim
    11/11/2024$45.00 → $65.00Buy → Hold
    Stifel
    10/2/2024$45.00 → $60.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $TEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Tempus AI with a new price target

      BTIG Research initiated coverage of Tempus AI with a rating of Buy and set a new price target of $60.00

      4/21/25 8:39:11 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus AI downgraded by Analyst with a new price target

      Analyst downgraded Tempus AI from Overweight to Neutral and set a new price target of $55.00 from $50.00 previously

      2/25/25 7:14:46 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus AI downgraded by William Blair

      William Blair downgraded Tempus AI from Outperform to Mkt Perform

      2/12/25 7:11:34 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $TEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $TEM
    Financials

    Live finance-specific insights

    See more
    • SEC Form SC 13G filed by Tempus AI Inc.

      SC 13G - Tempus AI, Inc. (0001717115) (Subject)

      11/12/24 5:00:02 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • SEC Form SC 13G filed by Tempus AI Inc.

      SC 13G - Tempus AI, Inc. (0001717115) (Subject)

      11/12/24 4:30:28 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Amendment: SEC Form SC 13D/A filed by Tempus AI Inc.

      SC 13D/A - Tempus AI, Inc. (0001717115) (Filed by)

      8/20/24 4:27:51 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus Reports First Quarter 2025 Results

      Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2025. Revenue increased 75.4% year-over-year to $255.7 million in the first quarter of 2025 Quarterly gross profit increased 99.8% year-over-year, reaching $155.2 million with continued gross margin improvement in both Genomics and Data and services Announced multi-year, strategic collaborations with AstraZeneca and Pathos to work together to build the largest multimodal foundation model in oncology, resulting in additional $200.0 million in data licensing and model development fees over the next

      5/6/25 4:01:00 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus to Report First Quarter 2025 Financial Results on May 6

      Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the first quarter of 2025 on Tuesday, May 6, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Conference ID: 4680302 Domestic Dial-in Number: (800) 715-9871 International Dial-in Number: (646) 307

      4/24/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24

      Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Conference ID: 9601821 Domestic Dial-in Number: (888) 596-4144 International Dial-i

      2/11/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $TEM
    SEC Filings

    See more
    • SEC Form 144 filed by Tempus AI Inc.

      144 - Tempus AI, Inc. (0001717115) (Subject)

      5/9/25 4:18:56 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Tempus AI Inc.

      SCHEDULE 13G/A - Tempus AI, Inc. (0001717115) (Subject)

      5/9/25 4:14:44 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • SEC Form 424B3 filed by Tempus AI Inc.

      424B3 - Tempus AI, Inc. (0001717115) (Filer)

      5/6/25 4:12:24 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $TEM
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $TEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Tempus Reports First Quarter 2025 Results

      Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2025. Revenue increased 75.4% year-over-year to $255.7 million in the first quarter of 2025 Quarterly gross profit increased 99.8% year-over-year, reaching $155.2 million with continued gross margin improvement in both Genomics and Data and services Announced multi-year, strategic collaborations with AstraZeneca and Pathos to work together to build the largest multimodal foundation model in oncology, resulting in additional $200.0 million in data licensing and model development fees over the next

      5/6/25 4:01:00 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • AI Healthcare Boom Gains Speed as Regulators and Innovators Align

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS Intelligence which polled C-suite executives at healthcare companies generating at least $1 billion in annual revenue, 90% already see positive ROI from investments in generative AI (GenAI). Analysts are projecting that by 2035 the gross value added by AI to the healthcare industry will be $461 billion on top of a baseline $2.26 trillion. Behind the scenes, several new AI healthcare tech developments are taking place, with updates rec

      5/5/25 12:35:00 PM ET
      $GEHC
      $SDGR
      $TEM
      $TVGN
      Medical Electronics
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Computer Software: Programming Data Processing
    • Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry

      Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant to aid psychiatrists in generating progress notes. Notetaker, which is available in Tempus Hub, ambiently records patient sessions to generate transcripts and clinical notes that can be seamlessly stored in patients' electronic health records. Notetaker complements Tempus' existing mental health platform designed to support clinicians in delivering personalized care. It joins other precision medicine solutions, including the Tempus nP pharmacogenomic test and PRO™, the company's patient reported

      5/5/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Chief Operating Officer Fukushima Ryan sold $1,047,239 worth of shares (20,000 units at $52.36), decreasing direct ownership by 2% to 884,460 units (SEC Form 4)

      4 - Tempus AI, Inc. (0001717115) (Issuer)

      5/8/25 4:30:06 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Director Epstein David R sold $19,795 worth of shares (370 units at $53.50), decreasing direct ownership by 1% to 25,914 units (SEC Form 4)

      4 - Tempus AI, Inc. (0001717115) (Issuer)

      5/5/25 4:15:22 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Chief Financial Officer Rogers James William was granted 4,372 shares, increasing direct ownership by 3% to 169,122 units (SEC Form 4)

      4 - Tempus AI, Inc. (0001717115) (Issuer)

      5/2/25 6:45:12 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $TEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Tempus Ai, Inc. exercised 9,218,800 in-the-money shares at a strike of $2.00 and bought $17,745,000 worth of shares (3,500,000 units at $5.07) (SEC Form 4)

      4 - Tempus AI, Inc. (0001717115) (Reporting)

      8/20/24 4:17:55 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology